Noticias de CLRB_US

Noticias del mercado

Últimas noticias sobre CLRB_US — 142 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CLRB_US ✕ 142 resultados
30/04/2026 CLRB_US — MSN
MSN Money
30/04/2026 CLRB_US — MSN ES ← EN
MSN Dinero

MSN Money

30/04/2026 CLRB_US — MSN
MSN Money
30/04/2026 CLRB_US — Stock Titan
Cellectar Biosciences (NASDAQ: CLRB) details governance, ownership and financings in 10-K/A
28/04/2026 CLRB_US — Finviz
CLRB
24/04/2026 CLRB_US — MEXC Exchange
CLRB Price Today: Cellectar Biosciences INC NEW Stock Price, Quote & Chart | MEXC

El precio CLRB en vivo hoy es de 2,65 USD. Realice un seguimiento de CLRB en MEXC con gráficos en vivo, movimientos diarios, estadísticas clave e información esencial sobre la negociación de acciones.

23/04/2026 CLRB_US — news.google.com
CLRB (Cellectar Biosciences Inc.) reports narrower than expected Q4 2025 loss, yet shares drop nearly 3 percent. - High Interest Stocks
23/04/2026 CLRB_US — tayninh.gov.vn
CLRB (Cellectar Biosciences Inc.) reports narrower than expected Q4 2025 loss, yet shares drop nearly 3 percent. - High Interest Stocks
22/04/2026 CLRB_US — sonla.gov.vn
CLRB (Cellectar Biosciences Inc.) reports narrower than expected Q4 2025 loss, yet shares drop nearly 3 percent.
22/04/2026 CLRB_US — Xã Châu Thành ES ← EN
CLRB (Cellectar Biosciences Inc.) informa una pérdida menor de lo esperado en el cuarto trimestre de 2025, pero las acciones caen casi un 3 por ciento. - Acciones de alto interés

CLRB (Cellectar Biosciences Inc.) informa una pérdida menor de lo esperado en el cuarto trimestre de 2025, pero las acciones caen casi un 3 por ciento. - Acciones de alto…

21/04/2026 CLRB_US — Investing.com Australia
Cellectar to present WM treatment data at oncology meeting By Investing.com
21/04/2026 CLRB_US — Investing.com ES ← EN
Cellectar presentará datos sobre el tratamiento de la WM en una reunión de oncología Por Investing.com
21/04/2026 CLRB_US — Investing.com
Cellectar to present WM treatment data at oncology meeting By Investing.com
21/04/2026 CLRB_US — Yahoo Finance
Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026
21/04/2026 CLRB_US — Investing News Network
Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026
21/04/2026 CLRB_US — Investing.com
Cellectar to present WM treatment data at oncology meeting
21/04/2026 CLRB_US — Quiver Quantitative
Cellectar Biosciences, Inc. Announces Acceptance of Abstract for Presentation on Iopofosine I-131 at ASCO Annual Meeting
21/04/2026 CLRB_US — Stock Titan
Cellectar takes cancer-drug data to ASCO for patients with no approved therapy
18/04/2026 CLRB_US — newser.com
CLRB (Cellectar Biosciences Inc.) reports narrower than expected Q4 2025 loss, yet shares drop nearly 3 percent. - Open Stock Signal Network
18/04/2026 CLRB_US — newser.com
CLRB (Cellectar Biosciences Inc.) reports narrower than expected Q4 2025 loss, yet shares drop nearly 3 percent.

Página 5 de 8

keyboard_arrow_up